MedTrace Logo

Minimal Equipment Training Approach to Improve Warfighter Performance

NCT05003778 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2023-11-29

No results posted yet for this study

Summary

The purpose of this project is to compare a minimal equipment training program with and without blood flow restriction (BFR) training to periodized concurrent resistance and endurance training. The outcomes of interest are Army Combat Fitness Test (ACFT) performance along with laboratory measures of performance, which include body composition, power, strength, and maximal aerobic capacity (VO2max). Additionally, based on the role of mechanical tension in connective tissue adaptation and the importance for chronic musculoskeletal health, tendon architecture will be assessed as well. Lastly, specific blood-based biomarkers will be analyzed in conjunction with questionnaires to determine the systemic physiological and psychological responses to training. Participants will be randomized into one of three training groups and will follow their respective program for 6 weeks. The three groups are traditional concurrent resistance and endurance training, minimal equipment training, and minimal equipment training with blood flow restriction (BFR).

Conditions

  • Healthy
  • Military Operations

Interventions

OTHER

Traditional equipment resistance training

Participants will undergo 6 weeks of traditional equipment resistance training

OTHER

Minimal equipment resistance training

Participants will undergo 6 weeks of minimal equipment resistance training

OTHER

Blood flow restriction training

Participants will undergo 6 weeks of blood flow restriction training

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of South Carolina

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-20
Primary Completion
2022-03-04
Completion
2022-06-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05003778 on ClinicalTrials.gov